Dextran Nanoparticle Synthesis and Properties

Iga Wasiak(NanoVelos (Poland)), Aleksandra Kulikowska(NanoVelos (Poland)), Magdalena Janczewska(Warsaw University of Technology), Magdalena Michalak(Warsaw University of Technology), Iwona A. Cymerman(International Institute of Molecular and Cell Biology), Andrzej Nagalski(NanoVelos (Poland)), Peter Kallinger(University of Vienna), Wladyslaw W. Szymanski(University of Vienna), Tomasz Ciach(Warsaw University of Technology)
PLoS ONE
January 11, 2016
Cited by 115Open Access
Full Text

Abstract

Dextran is widely exploited in medical products and as a component of drug-delivering nanoparticles (NPs). Here, we tested whether dextran can serve as the main substrate of NPs and form a stable backbone. We tested dextrans with several molecular masses under several synthesis conditions to optimize NP stability. The analysis of the obtained nanoparticles showed that dextran NPs that were synthesized from 70 kDa dextran with a 5% degree of oxidation of the polysaccharide chain and 50% substitution with dodecylamine formed a NP backbone composed of modified dextran subunits, the mean diameter of which in an aqueous environment was around 100 nm. Dextran NPs could be stored in a dry state and reassembled in water. Moreover, we found that different chemical moieties (e.g., drugs such as doxorubicin) can be attached to the dextran NPs via a pH-dependent bond that allows release of the drug with lowering pH. We conclude that dextran NPs are a promising nano drug carrier.


Related Papers

No related papers found

Powered by citation graph analysis